A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome

Journal of Pediatric Surgery - Tập 40 - Trang 763-768 - 2005
David L. Sigalet1,2, Gary R. Martin1, J. Decker Butzner1, Andre Buret3, Jonathan B. Meddings1
1GI Research Group, University of Calgary, Calgary, Alberta, Canada TZT SC7
2Department of Surgery, University of Calgary, Calgary, Alberta, Canada TZT SC7
3Mucosal Inflammation Research Groups, University of Calgary, Calgary, Alberta, Canada TZT SC7

Tài liệu tham khảo

Sigalet, 2001, Short bowel syndrome in infants and children: an overview, Semin Pediatr Surg, 10, 49, 10.1053/spsu.2001.22382 Vanderhoof, 1997, Short bowel syndrome in children and adults, Gastroenterology, 113, 1767, 10.1053/gast.1997.v113.pm9352883 Buchman, 2003, American Gastroenterological Association Medical Position Statement: short bowel syndrome and intestinal transplantation, Gastroenterology, 124, 1105, 10.1053/gast.2003.50139 Dowling, 1982, Small bowel adaptation and its regulation, Scand J Gastroenterol, 17, 53 Sigalet, 1998, Mechanisms underlying intestinal adaptation following massive intestinal resection in the rat, J Pediatr Surg, 33, 889, 10.1016/S0022-3468(98)90667-4 Kelly, 1998, Liver complications of pediatric parenteral nutrition—epidemiology, Nutrition, 14, 153, 10.1016/S0899-9007(97)00232-3 Barnard, 1995, Epidermal growth factor–related peptides and their relevance to gastrointestinal pathophysiology, Gastroenterology, 108, 564, 10.1016/0016-5085(95)90087-X Shin, 2000, Diminished epidermal growth factor levels in infants with necrotizing enterocolitis, J Pediatr Surg, 35, 173, 10.1016/S0022-3468(00)90005-8 Bashir, 2003, Effect of EGF administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice, Clin Sci, 105, 323, 10.1042/CS20030023 Berlanga-Acosta, 2001, Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats, Gut, 48, 803, 10.1136/gut.48.6.803 Playford, 1996, The epidermal growth factor receptor is present on the basolateral surface of enterocytes in the human gastrointestinal tract, Gut, 39, 262, 10.1136/gut.39.2.262 Vermeer, 2003, Segregation of receptor and ligand regulates activation of epithelial growth factor receptor, Nature, 422, 322, 10.1038/nature01440 Marti, 1989, Biological effects of epidermal growth factor with emphasis on the gastrointestinal tract and liver: an update, Hepatology, 9, 126, 10.1002/hep.1840090122 Helmrath, 1998, Adaptation after small bowel resection is attenuated by sialoadenectomy: the role for endogenous epidermal growth factor, Surgery, 124, 848, 10.1016/S0039-6060(98)70008-X O'Loughlin, 1994, Structural and functional adaptation following jejunal resection in rabbits: effect of epidermal growth factor, Gastroenterology, 107, 87, 10.1016/0016-5085(94)90064-7 Hardin, 1999, Effect of epidermal growth factor on enterocyte brush border surface area, Am J Physiol, 264, G312 Hardin, 1999, The effect of epidermal growth factor on brush border surface area and function in the distal remnant following resection in the rabbit, Gut, 44, 26, 10.1136/gut.44.1.26 Shin, 1998, Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route and timing of administration, J Surg Res, 77, 11, 10.1006/jsre.1998.5336 Buret, 1998, Effects of orally administered epidermal growth factor on enteropathogenic E. coli infection in rabbits, Infect Immun, 66, 4917, 10.1128/IAI.66.10.4917-4923.1998 Calnan, 2000, Potency and stability of C terminal truncated human epidermal growth factor, Gut, 47, 622, 10.1136/gut.47.5.622 Sham, 2002, Epidermal growth factor improves nutritional outcome in a rat model of short bowel syndrome, J Pediatr Surg, 37, 765, 10.1053/jpsu.2002.32273 Walker-Smith, 1985, Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy, Lancet, i, 1239, 10.1016/S0140-6736(85)90762-7 Sullivan, 1997, A pilot study of the safety and efficacy of epidermal growth factor (rEGF) in the treatment of severe necrotising enterocolitis, Gut, 41, A69 Martin, 2003, 3-0 Methylglucose absorption in vivo correlates with nutrient absorption and intestinal surface area in experimental short bowel syndrome, J Parenter Enteral Nutr, 27, 65, 10.1177/014860710302700165 Sigalet, 2004, 3-0 Methylglucose uptake as a marker of nutrient absorption and bowel length in pediatric patients, J Parenter Enteral Nutr, 28, 158, 10.1177/0148607104028003158 Anon: Canadian Dietary Association, 1998, Recommended guidelines, J Can Diet Assoc, 51, 388 Berlanga, 2002, Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage, Am J Pathol, 161, 373, 10.1016/S0002-9440(10)64192-2 Dvorak, 2003, Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model, Pediatr Res, 53, 426, 10.1203/01.PDR.0000050657.56817.E0